Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 
RMJ. 2022; 47(1): 112-115


Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis

Mamoora Arslaan, Nasim Karim, Mehr Fatima.

Abstract
Objective: To compare clinical efficacy of 1% metformin and alendronate gel in adjunct to scaling and root planning (SRP) on clinical and biochemical parameters in patients having moderate localized chronic periodontitis.
Methodology: In this randomized open label clinical trial, 60 systemically healthy, males and females aged 30-50 year, diagnosed with localized moderate chronic periodontitis were enrolled from Bahria Dental College Hospital by convenient sampling technique. Duration of study was 6 months. Participants with deepest periodontal pocket depth (PPD), clinical attachment loss (CAL), plaque index (PI) and mean sulcular bleeding index (mSBI) were included whereas those with history of periodontal therapy and mouthwashes were excluded. Patients were divided randomly into two groups each group consisting of 30 patients. Group A received Metformin 1% gel and Group B received Alendronate 1% gel, both intra-pocket with SRP at day 0. Clinical parameters were evaluated at day 0, 45 and 90. TNFα was evaluated by Eliza at day 0 and 90. Statistical analysis was done using SPSS version 23.
Results: Group A showed the significant reduction in PPD and CAL compared to group B while PI and mSBI were found non-significant. TNFα was significantly reduced in group A at day 90.
Conclusion: We found that 1% Metformin gel produced more beneficial effects in adjunct to SRP on clinical and biochemical parameters in comparison to 1% Alendronate gel.

Key words: Alendronate, chronic periodontitis, gingival crevicular fluid, Metformin, TNF-α.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mamoora Arslaan
Articles by Nasim Karim
Articles by Mehr Fatima
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. 2022; 47(1): 112-115.


Web Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. https://www.rmj.org.pk/?mno=105679 [Access: April 05, 2022].


AMA (American Medical Association) Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. 2022; 47(1): 112-115.



Vancouver/ICMJE Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. (2022), [cited April 05, 2022]; 47(1): 112-115.



Harvard Style

Arslaan, M., Karim, . N. & Fatima, M. (2022) Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ, 47 (1), 112-115.



Turabian Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. 2022. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. Rawal Medical Journal, 47 (1), 112-115.



Chicago Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. "Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis." Rawal Medical Journal 47 (2022), 112-115.



MLA (The Modern Language Association) Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. "Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis." Rawal Medical Journal 47.1 (2022), 112-115. Print.



APA (American Psychological Association) Style

Arslaan, M., Karim, . N. & Fatima, M. (2022) Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. Rawal Medical Journal, 47 (1), 112-115.








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Indexed in WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED,  Scopus, Web of Science and Tehqeeqat

                     Approved by the Higher Education Commission of Pakistan 


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.